ArticleJCO precision oncology2025

Fibroblast Growth Factor Receptor 3 Alteration Status and Outcomes on Immune Checkpoint Inhibitors in Patients With Metastatic Urothelial Carcinoma.

Shilpa Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.